Infusion of Dexmedetomidine Versus Lidocaine in Management of Acute Postoperative Pain After Modified Radical Mastectomy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

August 20, 2025

Study Completion Date

August 20, 2025

Conditions
InfusionDexmedetomidineLidocaineAcutePostoperative PainModified Radical Mastectomy
Interventions
DRUG

Dexmedetomidine

Patients will receive 1 μg/kg of intravenous dexmedetomidine over 10 min followed by an intravenous infusion of n 0.3-0.5 μg/kg/h.

DRUG

Lidocaine

Patients will receive a bolus of intravenous lidocaine 1.5mg/kg over 10 min followed by a continuous infusion of lidocaine 1.5-2 mg/kg/h.

Trial Locations (1)

12613

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER